Clinical Trials for Systemic Anti-tumor Activity and Safety of the Combination of SBRT and Concurrent PD-1 Blockade in Metastatic RCC

Find clinical trials for systemic anti-tumor activity and safety of the combination of sbrt and concurrent pd-1 blockade in metastatic rcc. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

Systemic Anti-tumor Activity and Safety of the Combination of SBRT and Concurrent PD-1 Blockade in Metastatic RCC.

NCT ID: NCT06327178

This clinical trial is studying the effects of a treatment called stereotactic body radiotherapy (SBRT) on patients with advanced kidney cancer, specifically a type known as metastatic clear renal ...

Recruiting

Type: observational Locations: Guangzhou, Guangdong, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions